DINALGEN 150 mg/ml solution for injection for cattle, pigs and horses

البلد: أيرلندا

اللغة: الإنجليزية

المصدر: HPRA (Health Products Regulatory Authority)

اشتر الآن

تأكيد الحساب خصائص المنتج (SPC)
12-06-2017
تأكيد الحساب DSU (DSU)
16-08-2023

العنصر النشط:

Ketoprofen

متاح من:

Ecuphar Veterinaria S.L.U.

ATC رمز:

QM01AE03

INN (الاسم الدولي):

Ketoprofen

جرعة:

150 milligram(s)/millilitre

الشكل الصيدلاني:

Solution for injection

نوع الوصفة الطبية :

POM: Prescription Only Medicine as defined in relevant national legislation

المجموعة العلاجية:

Cattle, Horses, Pigs

المجال العلاجي:

ketoprofen

الخصائص العلاجية:

N.S.A.I.D.

الوضع إذن:

Authorised

تاريخ الترخيص:

2010-09-24

خصائص المنتج

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
DINALGEN 150 mg/ml solution for injection for cattle, pigs and horses.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Ketoprofen
150 mg
EXCIPIENTS:
Benzyl alcohol (E1519)
10 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear colourless to yellowish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, pigs and horses.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle:
- Reduction of inflammation and pain associated with post-partum,
musculoskeletal disorders and lameness.
- Reduction of fever associated with bovine respiratory disease.
- Reduction of inflammation, fever and pain in acute clinical mastitis
in combination with antimicrobial therapy where
appropriate.
Pigs:
- Reduction of pyrexia in cases of respiratory disease and Postpartum
Dysglactia Syndrome-PDS-(Metritis Mastitis
Agalactia syndrome) in sows, in combination with antimicrobial
therapy, where appropriate.
Horses:
- Reduction of inflammation and pain associated with osteoarticular
and musculoskeletal disorders (lameness, laminitis,
osteoarthritis, synovitis, tendinitis, etc.).
-
Reduction of postoperative pain and inflammation.
-
Reduction of visceral pain associated with colic.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_2_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_1_
_3_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_

                                
                                اقرأ الوثيقة كاملة
                                
                            

تنبيهات البحث المتعلقة بهذا المنتج